BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 23687923)

  • 1. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
    Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
    Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
    Shi M; Guo XT; Shu MG; Chen FL; Li LW
    Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of hypoxia-targeting drugs as new cancer chemotherapeutics.
    Nagasawa H; Uto Y; Kirk KL; Hori H
    Biol Pharm Bull; 2006 Dec; 29(12):2335-42. PubMed ID: 17142959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer.
    Agani F; Jiang BH
    Curr Cancer Drug Targets; 2013 Mar; 13(3):245-51. PubMed ID: 23297826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.
    Wigerup C; Påhlman S; Bexell D
    Pharmacol Ther; 2016 Aug; 164():152-69. PubMed ID: 27139518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-directed drug strategies to target the tumor microenvironment.
    Hay MP; Hicks KO; Wang J
    Adv Exp Med Biol; 2014; 772():111-45. PubMed ID: 24272357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.
    Semenza GL
    Trends Pharmacol Sci; 2012 Apr; 33(4):207-14. PubMed ID: 22398146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypoxia: a therapeutic target].
    Fernández-Braña M
    Clin Transl Oncol; 2005 Dec; 7(11):475-6. PubMed ID: 16373057
    [No Abstract]   [Full Text] [Related]  

  • 9. HIF-1 signaling in drug resistance to chemotherapy.
    Warfel NA; El-Deiry WS
    Curr Med Chem; 2014; 21(26):3021-8. PubMed ID: 24735366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.
    Albadari N; Deng S; Li W
    Expert Opin Drug Discov; 2019 Jul; 14(7):667-682. PubMed ID: 31070059
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
    Rohwer N; Cramer T
    Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the molecular basis for tumour hypoxia.
    Carroll VA; Ashcroft M
    Expert Rev Mol Med; 2005 Apr; 7(6):1-16. PubMed ID: 15831177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation sensitization with redox modulators: a promising approach.
    Rosenberg A; Knox S
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):343-54. PubMed ID: 16414370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.
    Bache M; Kappler M; Said HM; Staab A; Vordermark D
    Curr Med Chem; 2008; 15(4):322-38. PubMed ID: 18288988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies.
    Brown JM
    Mol Med Today; 2000 Apr; 6(4):157-62. PubMed ID: 10740254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-mediated cancer stem cell resistance and targeted therapy.
    Sun X; Lv X; Yan Y; Zhao Y; Ma R; He M; Wei M
    Biomed Pharmacother; 2020 Oct; 130():110623. PubMed ID: 32791395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor hypoxia in cancer therapy.
    Brown JM
    Methods Enzymol; 2007; 435():297-321. PubMed ID: 17998060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome.
    Kim JY; Lee JY
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia: targeting the tumour.
    Boyle RG; Travers S
    Anticancer Agents Med Chem; 2006 Jul; 6(4):281-6. PubMed ID: 16842231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.